176 related articles for article (PubMed ID: 22989898)
1. [Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site: study design and advance construction of domestic research network].
Sato S; Yamamoto H; Qureshi AI; Palesch YY; Toyoda K;
Rinsho Shinkeigaku; 2012; 52(9):642-50. PubMed ID: 22989898
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.
Qureshi AI; Palesch YY
Neurocrit Care; 2011 Dec; 15(3):559-76. PubMed ID: 21626077
[TBL] [Abstract][Full Text] [Related]
3. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
[TBL] [Abstract][Full Text] [Related]
4. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
Qureshi AI; Palesch YY; Barsan WG; Hanley DF; Hsu CY; Martin RL; Moy CS; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Wang Y; Yamamoto H; Yoon BW;
N Engl J Med; 2016 Sep; 375(11):1033-43. PubMed ID: 27276234
[TBL] [Abstract][Full Text] [Related]
5. Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.
Tanaka K; Koga M; Fukuda-Doi M; Qureshi AI; Yamamoto H; Miwa K; Ihara M; Toyoda K;
Stroke; 2022 Jun; 53(6):1854-1862. PubMed ID: 35400202
[TBL] [Abstract][Full Text] [Related]
6. Run-up to participation in ATACH II in Japan.
Toyoda K; Sato S; Koga M; Yamamoto H; Nakagawara J; Furui E; Shiokawa Y; Hasegawa Y; Okuda S; Sakai N; Kimura K; Okada Y; Yoshimura S; Hoshino H; Uesaka Y; Nakashima T; Itoh Y; Ueda T; Nishi T; Gotoh J; Nagatsuka K; Arihiro S; Yamaguchi T; Minematsu K
J Vasc Interv Neurol; 2012 Aug; 5(supp):1-5. PubMed ID: 23230457
[TBL] [Abstract][Full Text] [Related]
7. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage.
Moullaali TJ; Wang X; Martin RH; Shipes VB; Qureshi AI; Anderson CS; Palesch YY
Int J Stroke; 2019 Apr; 14(3):321-328. PubMed ID: 30418098
[TBL] [Abstract][Full Text] [Related]
8. Management of Acute Hypertensive Response in Intracerebral Hemorrhage Patients After ATACH-2 Trial.
Majidi S; Suarez JI; Qureshi AI
Neurocrit Care; 2017 Oct; 27(2):249-258. PubMed ID: 28004328
[TBL] [Abstract][Full Text] [Related]
9. Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study.
Yamaguchi Y; Koga M; Sato S; Yamagami H; Todo K; Okuda S; Okada Y; Kimura K; Shiokawa Y; Kamiyama K; Itabashi R; Hasegawa Y; Kario K; Fujita K; Kumamoto M; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yoshimura S; Nagatsuka K; Toyoda K;
Cerebrovasc Dis; 2018; 46(3-4):118-124. PubMed ID: 30199854
[TBL] [Abstract][Full Text] [Related]
10. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.
Shoamanesh A; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel MJ; Ayres AM; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
JAMA Neurol; 2018 Jul; 75(7):850-859. PubMed ID: 29710119
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.
Qureshi AI; Huang W; Lobanova I; Barsan WG; Hanley DF; Hsu CY; Lin CL; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Yamamoto H;
JAMA Neurol; 2020 Nov; 77(11):1355-1365. PubMed ID: 32897310
[TBL] [Abstract][Full Text] [Related]
12. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.
Wang X; Arima H; Heeley E; Delcourt C; Huang Y; Wang J; Stapf C; Robinson T; Woodward M; Chalmers J; Anderson CS;
Hypertension; 2015 May; 65(5):1026-32. PubMed ID: 25801872
[TBL] [Abstract][Full Text] [Related]
13. [Medical therapy for intracranial hemorrhage: update blood pressure management for prevention and acute treatment].
Koga M; Toyoda K
Rinsho Shinkeigaku; 2012; 52(11):1110-2. PubMed ID: 23196532
[TBL] [Abstract][Full Text] [Related]
14. Intensive lowering of blood pressure in the acute phase of intracranial haemorrhage.
Bozzano V; Carandini T;
Intern Emerg Med; 2017 Apr; 12(3):379-380. PubMed ID: 28280979
[No Abstract] [Full Text] [Related]
15. Controlling blood pressure soon after intracerebral hemorrhage: The SAMURAI-ICH Study and its successors.
Toyoda K; Koga M;
Hypertens Res; 2022 Apr; 45(4):583-590. PubMed ID: 35260801
[TBL] [Abstract][Full Text] [Related]
16. Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study.
Koga M; Arihiro S; Hasegawa Y; Shiokawa Y; Okada Y; Kimura K; Furui E; Nakagawara J; Yamagami H; Kario K; Okuda S; Tokunaga K; Takizawa H; Takasugi J; Sato S; Nagatsuka K; Minematsu K; Toyoda K;
J Stroke Cerebrovasc Dis; 2014; 23(10):2780-2787. PubMed ID: 25314943
[TBL] [Abstract][Full Text] [Related]
17. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
[TBL] [Abstract][Full Text] [Related]
18. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).
Koga M; Toyoda K; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Osaki M; Miyagi T; Endo K; Nagatsuka K; Minematsu K;
J Hypertens; 2012 Dec; 30(12):2357-64. PubMed ID: 22990355
[TBL] [Abstract][Full Text] [Related]
19. Blood Pressure-Attained Analysis of ATACH 2 Trial.
Qureshi AI; Palesch YY; Foster LD; Barsan WG; Goldstein JN; Hanley DF; Hsu CY; Moy CS; Qureshi MH; Silbergleit R; Suarez JI; Toyoda K; Yamamoto H;
Stroke; 2018 Jun; 49(6):1412-1418. PubMed ID: 29789395
[TBL] [Abstract][Full Text] [Related]
20. Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments.
Yogendrakumar V; Ramsay T; Menon BK; Qureshi AI; Saver JL; Dowlatshahi D
Neurology; 2021 Aug; 97(8):e755-e764. PubMed ID: 34144995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
